BAYTRIL INJECTION SOLUTION

দেশ: কানাডা

ভাষা: ইংরেজি

সূত্র: Health Canada

সক্রিয় উপাদান:

ENROFLOXACIN

থেকে পাওয়া:

ELANCO CANADA LIMITED

ডোজ:

50MG

ফার্মাসিউটিকাল ফর্ম:

SOLUTION

রচনা:

ENROFLOXACIN 50MG

প্রশাসন রুট:

INTRAMUSCULAR

প্যাকেজ ইউনিট:

15G/50G

প্রেসক্রিপশন টাইপ:

Prescription

থেরাপিউটিক গ্রুপ:

DOGS

পণ্য সারাংশ:

Active ingredient group (AIG) number: 0121066003

অনুমোদন অবস্থা:

APPROVED

অনুমোদন তারিখ:

2020-12-09

তথ্য লিফলেট

Pr
Baytril Injection Bottle
08Oct2020
PR
BAYTRIL
INJECTION
1
BOTTLE
2
LEFT PANEL
3
DIN 02169428
4
Pr
Baytril
5
(enrofloxacin)/(enrofloxacine)
6
For Veterinary Use Only
7
Pour usage vétérinaire seulement
8
Antibacterial Injectable Solution
9
Solution antibactérienne injectable
10
50 MG/ML
11
STERILE/STÉRILE
12

13
50 ML
14

15
16
CENTER PANEL
17
For the treatment of infections caused by susceptible bacterial
pathogens in dogs
18
19
Pour le traitement des infections causées par les bactéries
pathogènes sensibles chez
20
le chien
21
22
EACH ML CONTAINS:
23
Enrofloxacin 50 mg, N-Butyl alcohol 30 mg, potassium hydroxide for pH
adjustment and
24
water for injection, q.s.
25
26
CONTENU D’UN MILLILITRE:
27
50 mg d’enrofloxacine, 30 mg d’alcool butylique normal, de
l’hydroxyde de potassium
28
pour ajuster le pH et de l’eau pour injection, autant qu’il est
nécessaire.
29
30
RIGHT PANEL
31
READ PACKAGE INSERT BEFORE USING THIS DRUG.
32
CONSULTER LE FEUILLET DE RENSEIGNEMENTS AVANT D’ADMINISTRER CE
33
MÉDICAMENT.
34
35
Elanco Canada Limited
36
150 Research Lane, Suite 120
37
Guelph, Ontario N1G 4T2
38
39
Lot :
40
Exp.:
41
Pr
Baytril Injection Package Insert
08Oct2020
PR
BAYTRIL
INJECTION
1
PACKAGE INSERT
2
Pr
Baytril
3
(enrofloxacin)
4
Antimicrobial Injectable Solution
5
FOR VETERINARY USE ONLY
6
7
DESCRIPTION: Enrofloxacin is a synthetic chemo-therapeutic agent from
the class of
8
the quinolone carboxylic acid derivatives. It has antibacterial
activity against a broad
9
spectrum of Gram negative and Gram positive bacteria (see Table 1). It
is rapidly
10
absorbed from the digestive tract, penetrating into all measured body
tissues and fluids
11
(see Table 2). Each mL of injectable solution contains: enrofloxacin
50 mg, n-butyl
12
alcohol 30 mg, potassium hydroxide for pH adjustment and water for
injection, q.s.
13
14
CHEMICAL NOMENCLATURE: 1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-
15
6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid.
16
17
ACTIONS:
1